Physician profile
Brett Thomas
NPI 1548848492
$1,494.78
in general payments reported to CMS, 2019-2025
18 companies · $1,471 in 2025
The $1,471 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $23.65 · 2025: $1,471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,494.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $200.07 | 2025 | |
| Janssen Biotech, INC. | $189.89 | 2025 | Tremfya |
| Galderma Laboratories, L.P. | $180.63 | 2025 | Nemluvio |
| Leo Pharma INC. | $162.16 | 2025 | Anzupgo |
| Lilly USA, LLC | $141.94 | 2025 | Ebglyss, Taltz |
| Arcutis Biotherapeutics, INC. | $121.04 | 2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $82.07 | 2025 | Libtayo, Dupixent |
| Pfizer INC. | $56.49 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.62 | 2025 | Spevigo |
| Amgen INC. | $49.64 | 2024-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $44.16 | 2025 | |
| Novartis Pharmaceuticals Corporation | $43.72 | 2025 | |
| Organon LLC | $42.57 | 2025 | Hadlima, Vtama |
| Ucb, INC. | $42.42 | 2025 | Bimzelx |
| Abbvie INC. | $37.82 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $23.42 | 2025 | Puraply Wound Matrix |
| Biowound Solutions, INC. | $13.18 | 2025 | Bio-Connekt |
| Mayne Pharma Commercial LLC | $7.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.